HIV Infection and Heart Failure Outcomes in Women
Sumbal Janjua(St. Elizabeth's Medical Center), Tomas G. Neilan(Albert Einstein College of Medicine), Udo Hoffmann(Duke Medical Center), S Grinspoon(Harvard University), Bálint Szilveszter(Harvard University), Markella V. Zanni(Harvard University), Pedro V. Staziaki(Harvard University), Susan Regan(Massachusetts General Hospital), Daniel Addison(The University of Texas Southwestern Medical Center), Virginia A. Triant(Brigham and Women's Hospital)
Cited by 58
Related Papers
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
|The Lancet|2022|955
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767